Dinora Inc
- Assets
- $882.0k
- Revenue
- $70.1k
- Investments
- $0.0
- Employees
- 0
- Location
- Washington, DC
- Founding
- 06/2005
- Data as of
- 12/2022
- EIN
- 30-0283980
Organization Overview
Dinora Inc is located in Washington, DC. The organization was established in 2005. According to its NTEE Classification (H51) the organization is classified as: Arthritis Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Dinora Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Dinora Inc generated $70.1k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (32.2%) each year. All expenses for the organization totaled $31.0k during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (41.4%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO SUPPORT CHARITABLE AND EDUCATIONAL ACTIVITIES THAT PROMOTE THE CLINICAL APPLICATION OF UNIQUE THEORIES AND THERAPIES TO TREAT, PREVENT AND CURE ARTHRITIS THROUGH FUNDING STUDIES, EDUCATIONAL SEMINARS & MEDICAL PUBLICATIONS THAT PROMOTE NEW THERAPIES & TREATMENT
Describe the Organization's Program Activity:
Part 3 - Line 4a
MYOSITIS WORKING GROUP - THE OMERACT MYOSITIS WORKING GROUP IS AN INTERNATIONAL COLLABORATION OF WELL-KNOWN CLINICAL RESEARCHERS, PATIENTS, AND STATISTICIANS. THE AIM OF THE WORKING GROUP IS TO DEVELOP OUTCOME MEASURES BASED ON PATIENTS' EXPERIENCES AND TO VALIDATE THESE MEASURES THOROUGHLY TO USE IN CLINICAL TRIALS.
INTERNATIONAL RHEUMATOLOGY COLLEAGUES DINNER - INITIATED IN 2000, THE IRC DINNER PROVIDES THE OPPORTUNITY FOR RHEUMATOLOGISTS TO BECOME UPDATED ON CURRENT CLINICAL RESEARCH ACTIVITIES. GIVEN THE RANGE OF RHEUMATOLOGIC DISORDERS, AND THE EVER-INCREASING NUMBER OF DIAGNOSTIC PROCEDURES AND TREATMENT OPTIONS, IT IS IMPORTANT TO PROVIDE CLINICIANS WITH INFORMATION TO UTILIZE THE MOST EFFECTIVE TREATMENTS TO ENSURE OPTIMAL PATIENT OUTCOMES. IT IS ALSO IMPORTANT FOR CLINICIANS AND RESEARCHERS TO ENHANCE THEIR KNOWLEDGE OF RESEARCH CURRENTLY BEING CONDUCTED AND THE BREAKTHROUGHS IN UNDERSTANDING THE UNDERLYING PATHOPHYSIOLOGY OF VARIOUS RHEUMATIC DISEASES WHICH MAY LEAD TO THE AVAILABILITY OF NEW TARGETED THERAPIES.
PROACTIVE - INITIATING AND SUPPORTING A PUBLIC PRIVATE, PRE-COMPETITIVE COLLABORATION AMONG A BROAD SPECTRUM OF STAKEHOLDERS, INCLUDING ACADEMIA, GOVERNMENT AGENCIES, INDUSTRY, PROFESSIONAL ORGANIZATIONS, AND PATIENT ORGANIZATIONS WITH THE GOAL OF SHARING DATA AND INNOVATIVE THINKING ABOUT THE DEVELOPMENT OF OSTEOARTHRITIS (OA) OUTCOME MEASURES FOR CLINICAL TRIALS OF THERAPIES AIMED AT SLOWING OA PROGRESSION.THE FOOD AND DRUG ADMINISTRATION APPROVED PROACTIVE'S APPLICATION SEEKING PARTICIPATION BY INDIVIDUALS FROM THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) TO ENGAGE IN THE ACTIVITIES OF THE CONSORTIUM.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Valorie Thompson Director | OfficerTrustee | 1 | $0 |
Anthony A Saridakis Secretary/treasurer | OfficerTrustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $70,000 |
| Investment income | $74 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $70,074 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $1,250 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,366 |
| All other expenses | $0 |
| Total functional expenses | $31,021 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $882,021 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $882,021 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $1,084 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $1,084 |
| Net assets without donor restrictions | $880,937 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $882,021 |